Metformin for Parkinson's Disease: Safety and Benefit
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether metformin, a common diabetes drug, is safe and helpful for people with Parkinson's disease who are already on standard treatment. It might help improve symptoms or slow the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 70 years old.
- You must have a confirmed diagnosis of Parkinson's disease.
- You must be currently taking the combination of levodopa and carbidopa.
- You cannot have other conditions like diabetes, heart disease, or certain other disorders.
- You must not be pregnant or breastfeeding, and you must not have a history of alcohol abuse or sensitivity to metformin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests whether sitagliptin, a diabetes drug, can slow the progression of early Parkinson's disease. It aims to see if the medication can protect brain cells and reduce symptoms, potentially offering a new way to treat Parkinson's.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This trial tests if metformin, a common diabetes drug, can help people with gout. It aims to see if the drug is safe and effective for reducing gout symptoms.
This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.
This trial tests a long-acting metformin pill in people with both type 2 diabetes and coronary heart disease. It aims to see if metformin can safely help control blood sugar in this specific group.
Hear when a new Parkinsons Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.